BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Thermo Fisher Scientific
TMO
|
+$415M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$247M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$186M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$179M |
| 5 |
Advanced Micro Devices
AMD
|
+$117M |
Top Sells
| 1 |
Apple
AAPL
|
+$547M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$533M |
| 3 |
Microsoft
MSFT
|
+$479M |
| 4 |
Amazon
AMZN
|
+$316M |
| 5 |
Diageo
DEO
|
+$288M |
Sector Composition
| 1 | Technology | 16.61% |
| 2 | Financials | 9.93% |
| 3 | Healthcare | 9.28% |
| 4 | Consumer Discretionary | 8.86% |
| 5 | Industrials | 6.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1701
ACI Worldwide
ACIW
$5.18B
| $998K | ﹤0.01% |
47,759
-45,942
| -49% | -$960K |
|
1702
Nurix Therapeutics
NRIX
$691M
| $996K | ﹤0.01% |
+76,415
| New | +$996K |
|
1703
Edgewell Personal Care
EPC
$1.01B
| $995K | ﹤0.01% |
26,595
+6,647
| +33% | +$249K |
|
1704
Red Rock Resorts
RRR
$3.65B
| $994K | ﹤0.01% |
29,014
+10,421
| +56% | +$357K |
|
1705
BancFirst
BANF
$4.45B
| $992K | ﹤0.01% |
11,092
-8,136
| -42% | -$728K |
|
1706
Dorman Products
DORM
$4.93B
| $992K | ﹤0.01% |
12,075
+3,498
| +41% | +$287K |
|
1707
Carter's
CRI
$1.08B
| $991K | ﹤0.01% |
15,118
-24,677
| -62% | -$1.62M |
|
1708
N-able
NABL
$1.54B
| $989K | ﹤0.01% |
+107,129
| New | +$989K |
|
1709
Kezar Life Sciences
KZR
$28.9M
| $986K | ﹤0.01% |
11,455
+9,807
| +595% | +$844K |
|
1710
Heron Therapeutics
HRTX
$193M
| $986K | ﹤0.01% |
233,540
+198,924
| +575% | +$839K |
|
1711
Hudson Technologies
HDSN
$444M
| $983K | ﹤0.01% |
133,785
-99,174
| -43% | -$729K |
|
1712
Nelnet
NNI
$4.46B
| $980K | ﹤0.01% |
12,374
+4,616
| +59% | +$366K |
|
1713
First Commonwealth Financial
FCF
$1.84B
| $980K | ﹤0.01% |
76,301
+2,790
| +4% | +$35.8K |
|
1714
FuelCell Energy
FCEL
$222M
| $980K | ﹤0.01% |
9,575
+3,305
| +53% | +$338K |
|
1715
BellRing Brands
BRBR
$4.8B
| $977K | ﹤0.01% |
+47,418
| New | +$977K |
|
1716
Bright Horizons
BFAM
$6.45B
| $971K | ﹤0.01% |
16,835
+12,448
| +284% | +$718K |
|
1717
Plexus
PLXS
$3.73B
| $970K | ﹤0.01% |
11,078
+2,586
| +30% | +$226K |
|
|
SCRM
1718
DELISTED
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
| $969K | ﹤0.01% |
+105,167
| New | +$969K |
|
1719
EastGroup Properties
EGP
$8.9B
| $966K | ﹤0.01% |
6,690
+1,847
| +38% | +$267K |
|
1720
CSG Systems International
CSGS
$1.86B
| $965K | ﹤0.01% |
18,251
-22,663
| -55% | -$1.2M |
|
1721
Digi International
DGII
$1.33B
| $965K | ﹤0.01% |
27,913
+17,017
| +156% | +$588K |
|
1722
Sangamo Therapeutics
SGMO
$152M
| $962K | ﹤0.01% |
196,331
+164,006
| +507% | +$804K |
|
1723
Turkcell
TKC
$4.86B
| $962K | ﹤0.01% |
361,550
-67,078
| -16% | -$178K |
|
1724
Collegium Pharmaceutical
COLL
$1.18B
| $962K | ﹤0.01% |
60,019
+20,759
| +53% | +$333K |
|
|
FBC
1725
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $959K | ﹤0.01% |
28,724
+8,776
| +44% | +$293K |
|